About this trial
This work aims at elucidating the role of MRI complementary T2 mapping in assessment of the articular knee cartilage for improving sensitivity of detection of early stage of osteoarthritis
Eligibility criteria
This trial accepts healthy volunteersQualifiers
patients with clinical evidence of osteoarthritis
Disqualifiers
• contraindications for MRI such as claustrophobia, heart pacemaker and ferromagnetic implants
patients in which the misaligned images or distortions due to motion artifacts made the interpretation of the MRI unreliable.
Patients with previous knee operation
Trial population
any patient with knee pain with no history of previous lustrophobiaoperation and has no metallic element inside his body with no ca
Trial design
Case-crossover
Cross-sectional
Treatments tested in this trial
MRI
DeviceDevice that use coil to image asses the articular cartilage of the knee
Treatment groups
Trial outcomes
Primary outcomes
This work aims at elucidating the role of MRI complementary T2 mapping to measure the changes in T2 relaxation time of the articular knee cartilage in healthy group which there number will be 28 and pateints with early osteoarthritis there number 28
to detect the value of adding T2 mapping to routine MRI in assessment of the articular cartilage in knee osteoarthritis
Secondary outcomes
This work aims at quantitive stratification of osteoarthrtic changes and its impact on treatement
to detect the value of adding T2 mapping to routine MRI in assessment of knee articular cartilage in knee osteoarthritis
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: